| P50 | author | Francesco Baratta | Q59206190 |
| | Maria Del Ben | Q61126339 |
| | Francesco Angelico | Q91970179 |
| | Francesco Violi | Q37834358 |
| | Daniele Pastori | Q42841662 |
| | Marta Novo | Q43149095 |
| P2093 | author name string | Nicholas Cocomello | |
| P2860 | cites work | Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease | Q26827665 |
| | The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease | Q27002905 |
| | Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis | Q28084150 |
| | Non-alcoholic fatty liver disease and liver transplantation | Q30251746 |
| | Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study | Q31798350 |
| | Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis | Q33724815 |
| | Third Universal Definition of Myocardial Infarction | Q56627595 |
| | Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract | Q56984696 |
| | Gender differences in the association between education and the incidence of cardiovascular events in Northern Italy | Q58109576 |
| | Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women | Q61162458 |
| | Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III | Q68755816 |
| | The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation | Q81350918 |
| | Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals | Q84177198 |
| | High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome | Q85207624 |
| | Remnant cholesterol: "Non-(HDL-C + LDL-C)" as a coronary artery disease risk factor | Q85780687 |
| | Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease | Q88524844 |
| | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. | Q33844463 |
| | Remnant lipoproteins as strong key particles to atherogenesis | Q34989130 |
| | Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease | Q35602513 |
| | The Framingham risk score and heart disease in nonalcoholic fatty liver disease. | Q35946523 |
| | Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis | Q36134867 |
| | Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis | Q36751392 |
| | Dyslipidemia in patients with nonalcoholic fatty liver disease. | Q36845703 |
| | Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies | Q36956660 |
| | Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease | Q37596189 |
| | Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease | Q38858941 |
| | Under-prescription of statins in patients with non-alcoholic fatty liver disease. | Q40425158 |
| | Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus | Q40504139 |
| | Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease | Q40810473 |
| | Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors | Q41209308 |
| | Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia | Q43822410 |
| | Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease | Q45187039 |
| | Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study | Q46537801 |
| | The potential role of statins in treating liver disease. | Q50067122 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| | lipoprotein | Q28350 |
| | non-alcoholic fatty liver | Q66299798 |
| P577 | publication date | 2018-10-23 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease | |
| P478 | volume | 7 | |